Fake medicines pose a serious hazard to public health. But in our country, spurious medicines are readily sold and distributed. Such spurious medicines are the main reason for the outbreak of serious diseases. Swiss-based company has launched an initiative, titled Access Program, to put an end to the sale of such medicines.
Under this programme, patients who cannot afford quality medicines can get these medicines for just $1 per month per treatment. What makes this even better is the fact that these medicines are not only FDA-approved, but they are also authentic and of premium quality.
Nuzair A Virani